July 11, 2023 Comments Off on New patent for Pharmacyclics Inc drug IMBRUVICA Posted in: Patent Added Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in three NDAs. It is available from one supplier. There are fifty-five patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appe…
July 11, 2023 Comments Off on New patent for Allergan drug LINZESS Posted in: Patent Added Annual Drug Patent Expirations for LINZESS Linzess is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are twelve patents protecting…
The post New patent for Allergan drug LINZESS appeared first on DrugPa…
